Published in Cell Stem Cell on September 03, 2010
Retracted Bidirectional developmental potential in reprogrammed cells with acquired pluripotency. Nature (2014) 4.62
Direct reprogramming of mouse fibroblasts to neural progenitors. Proc Natl Acad Sci U S A (2011) 3.93
Exit from pluripotency is gated by intracellular redistribution of the bHLH transcription factor Tfe3. Cell (2013) 3.15
Esrrb is a direct Nanog target gene that can substitute for Nanog function in pluripotent cells. Cell Stem Cell (2012) 2.93
Prmt5 is essential for early mouse development and acts in the cytoplasm to maintain ES cell pluripotency. Genes Dev (2010) 2.59
The transcriptional and signalling networks of pluripotency. Nat Cell Biol (2011) 2.54
esBAF facilitates pluripotency by conditioning the genome for LIF/STAT3 signalling and by regulating polycomb function. Nat Cell Biol (2011) 2.29
Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells. Proc Natl Acad Sci U S A (2011) 2.08
Nonreceptor tyrosine kinase BMX maintains self-renewal and tumorigenic potential of glioblastoma stem cells by activating STAT3. Cancer Cell (2011) 2.04
Nanog overcomes reprogramming barriers and induces pluripotency in minimal conditions. Curr Biol (2010) 1.86
Chromatin dynamics during cellular reprogramming. Nature (2013) 1.79
G-CSF Promotes Neuroblastoma Tumorigenicity and Metastasis via STAT3-Dependent Cancer Stem Cell Activation. Cancer Res (2015) 1.74
Epiblast stem cell-based system reveals reprogramming synergy of germline factors. Cell Stem Cell (2012) 1.54
A genome-wide screen in EpiSCs identifies Nr5a nuclear receptors as potent inducers of ground state pluripotency. Development (2010) 1.51
Embryonic stem cell self-renewal pathways converge on the transcription factor Tfcp2l1. EMBO J (2013) 1.50
Transient acquisition of pluripotency during somatic cell transdifferentiation with iPSC reprogramming factors. Nat Biotechnol (2015) 1.48
Identification of the missing pluripotency mediator downstream of leukaemia inhibitory factor. EMBO J (2013) 1.46
Regulation of embryonic stem cell self-renewal and pluripotency by leukaemia inhibitory factor. Biochem J (2011) 1.41
Reprogramming to pluripotency: stepwise resetting of the epigenetic landscape. Cell Res (2011) 1.41
G-CSF receptor positive neuroblastoma subpopulations are enriched in chemotherapy-resistant or relapsed tumors and are highly tumorigenic. Cancer Res (2013) 1.41
Retracted Cell biology: Potency unchained. Nature (2014) 1.39
JAK/STAT3 signalling is sufficient and dominant over antagonistic cues for the establishment of naive pluripotency. Nat Commun (2012) 1.37
Enhanced self-renewal of hematopoietic stem/progenitor cells mediated by the stem cell gene Sall4. J Hematol Oncol (2011) 1.22
The liberation of embryonic stem cells. PLoS Genet (2011) 1.20
A decade of transcription factor-mediated reprogramming to pluripotency. Nat Rev Mol Cell Biol (2016) 1.16
Accessing naïve human pluripotency. Curr Opin Genet Dev (2012) 1.13
Loss of androgen receptor expression promotes a stem-like cell phenotype in prostate cancer through STAT3 signaling. Cancer Res (2013) 1.13
Histone variant macroH2A marks embryonic differentiation in vivo and acts as an epigenetic barrier to induced pluripotency. J Cell Sci (2012) 1.10
Inhibition of platelet-derived growth factor receptor signaling regulates Oct4 and Nanog expression, cell shape, and mesenchymal stem cell potency. Stem Cells (2012) 1.09
Rebuilding pluripotency from primordial germ cells. Stem Cell Reports (2013) 1.09
NANOG amplifies STAT3 activation and they synergistically induce the naive pluripotent program. Curr Biol (2014) 1.05
TGF-β family signaling in stem cells. Biochim Biophys Acta (2012) 1.01
Reinforcement of STAT3 activity reprogrammes human embryonic stem cells to naive-like pluripotency. Nat Commun (2015) 0.99
The germ cell determinant Blimp1 is not required for derivation of pluripotent stem cells. Cell Stem Cell (2012) 0.97
STAT3 phosphorylation at tyrosine 705 and serine 727 differentially regulates mouse ESC fates. Stem Cells (2014) 0.94
Concise review: Pluripotency and the transcriptional inactivation of the female Mammalian X chromosome. Stem Cells (2012) 0.94
Leukemia inhibitory factor (LIF). Cytokine Growth Factor Rev (2015) 0.93
The role of pluripotency gene regulatory network components in mediating transitions between pluripotent cell states. Curr Opin Genet Dev (2013) 0.93
Transcription factor heterogeneity and epiblast pluripotency. Philos Trans R Soc Lond B Biol Sci (2011) 0.92
Mechanistic insights into reprogramming to induced pluripotency. J Cell Physiol (2011) 0.92
Nanog heterogeneity: tilting at windmills? Cell Stem Cell (2013) 0.90
Molecular basis of embryonic stem cell self-renewal: from signaling pathways to pluripotency network. Cell Mol Life Sci (2015) 0.90
Modulation of pluripotency in the porcine embryo and iPS cells. PLoS One (2012) 0.90
Troika of the mouse blastocyst: lineage segregation and stem cells. Curr Stem Cell Res Ther (2012) 0.90
Cyclin A1 is essential for setting the pluripotent state and reducing tumorigenicity of induced pluripotent stem cells. Stem Cells Dev (2012) 0.89
JAK-STAT3 and somatic cell reprogramming. JAKSTAT (2013) 0.88
Establishment of leukemia inhibitory factor (LIF)-independent iPS cells with potentiated Oct4. Stem Cell Res (2015) 0.87
A virus-free poly-promoter vector induces pluripotency in quiescent bovine cells under chemically defined conditions of dual kinase inhibition. PLoS One (2011) 0.85
Chemical approaches to cell reprogramming. Curr Opin Genet Dev (2014) 0.85
Learning the molecular mechanisms of the reprogramming factors: let's start from microRNAs. Mol Biosyst (2012) 0.84
Mapping the networks for pluripotency. Philos Trans R Soc Lond B Biol Sci (2011) 0.84
Stat3 promotes mitochondrial transcription and oxidative respiration during maintenance and induction of naive pluripotency. EMBO J (2016) 0.83
Toward directed reprogramming through exogenous factors. Curr Opin Genet Dev (2013) 0.83
Histone lysine-specific demethylase 1 (LSD1) protein is involved in Sal-like protein 4 (SALL4)-mediated transcriptional repression in hematopoietic stem cells. J Biol Chem (2013) 0.83
The SIN3A/HDAC Corepressor Complex Functionally Cooperates with NANOG to Promote Pluripotency. Cell Rep (2017) 0.82
Cell signalling pathways underlying induced pluripotent stem cell reprogramming. World J Stem Cells (2014) 0.82
The Role of the Leukemia Inhibitory Factor (LIF) - Pathway in Derivation and Maintenance of Murine Pluripotent Stem Cells. Genes (Basel) (2011) 0.82
Efficient reprogramming of naïve-like induced pluripotent stem cells from porcine adipose-derived stem cells with a feeder-independent and serum-free system. PLoS One (2014) 0.82
Transcription factor-mediated reprogramming toward hematopoietic stem cells. EMBO J (2015) 0.81
Functions of the Drosophila JAK-STAT pathway: Lessons from stem cells. JAKSTAT (2012) 0.81
CCL2 enhances pluripotency of human induced pluripotent stem cells by activating hypoxia related genes. Sci Rep (2014) 0.81
Hes1 desynchronizes differentiation of pluripotent cells by modulating STAT3 activity. Stem Cells (2013) 0.81
Wnt/β-catenin and LIF-Stat3 signaling pathways converge on Sp5 to promote mouse embryonic stem cell self-renewal. J Cell Sci (2015) 0.81
Inositol Polyphosphate-5-Phosphatase F (INPP5F) inhibits STAT3 activity and suppresses gliomas tumorigenicity. Sci Rep (2014) 0.79
Local BMP-SMAD1 signaling increases LIF receptor-dependent STAT3 responsiveness and primed-to-naive mouse pluripotent stem cell conversion frequency. Stem Cell Reports (2014) 0.79
Embryonic Stem Cells Promoting Macrophage Survival and Function are Crucial for Teratoma Development. Front Immunol (2014) 0.78
Signaling pathways in induced naïve pluripotency. Curr Opin Genet Dev (2014) 0.78
Minireview: the diverse roles of nuclear receptors in the regulation of embryonic stem cell pluripotency. Mol Endocrinol (2013) 0.78
The STATs on naive iPSC reprogramming. Cell Stem Cell (2010) 0.78
Epidermal stem cells undergo age-associated changes. Aging (Albany NY) (2013) 0.78
Establishment of a primed pluripotent epiblast stem cell in FGF4-based conditions. Sci Rep (2014) 0.77
Leukemia inhibitory factor (LIF) withdrawal activates mTOR signaling pathway in mouse embryonic stem cells through the MEK/ERK/TSC2 pathway. Cell Death Dis (2016) 0.77
esBAF safeguards Stat3 binding to maintain pluripotency. Nat Cell Biol (2011) 0.77
Pluripotent states of human embryonic stem cells. Cell Reprogram (2014) 0.76
Signalling Through Retinoic Acid Receptors is Required for Reprogramming of Both Mouse Embryonic Fibroblast Cells and Epiblast Stem Cells to Induced Pluripotent Stem Cells. Stem Cells (2015) 0.76
The Androgen Receptor Bridges Stem Cell-Associated Signaling Nodes in Prostate Stem Cells. Stem Cells Int (2016) 0.76
Retracted Regulatory factors of induced pluripotency: current status. Stem Cell Investig (2014) 0.75
Tankyrase inhibition promotes a stable human naïve pluripotent state with improved functionality. Development (2016) 0.75
Knockdown of Brm and Baf170, Components of Chromatin Remodeling Complex, Facilitates Reprogramming of Somatic Cells. Stem Cells Dev (2015) 0.75
Regulation of the JMJD3 (KDM6B) histone demethylase in glioblastoma stem cells by STAT3. PLoS One (2017) 0.75
Mechanisms underlying the formation of induced pluripotent stem cells. Wiley Interdiscip Rev Dev Biol (2015) 0.75
Differential gene expression in mouse spermatogonial stem cells and embryonic stem cells. Int J Mol Med (2016) 0.75
Epigenetic reprogramming: Prdm14 hits the accelerator. EMBO J (2012) 0.75
Ggnbp2 Is Essential for Pregnancy Success via Regulation of Mouse Trophoblast Stem Cell Proliferation and Differentiation. Biol Reprod (2016) 0.75
Primate embryogenesis predicts the hallmarks of human naïve pluripotency. Development (2017) 0.75
Selinexor-induced thrombocytopenia results from inhibition of thrombopoietin signaling in early megakaryopoiesis. Blood (2017) 0.75
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
Embryonic stem cell lines derived from human blastocysts. Science (1998) 65.53
Establishment in culture of pluripotential cells from mouse embryos. Nature (1981) 30.49
Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell (2003) 20.16
The ground state of embryonic stem cell self-renewal. Nature (2008) 19.44
Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A (1981) 18.96
New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature (2007) 13.54
Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature (1988) 13.21
Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature (2007) 11.72
Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol (2008) 8.55
Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev (1998) 8.51
Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature (1988) 7.61
Role of the murine reprogramming factors in the induction of pluripotency. Cell (2009) 7.46
Nanog is the gateway to the pluripotent ground state. Cell (2009) 7.27
Naive and primed pluripotent states. Cell Stem Cell (2009) 7.15
Capture of authentic embryonic stem cells from rat blastocysts. Cell (2008) 6.60
Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines. Nature (1984) 6.54
Klf4 reverts developmentally programmed restriction of ground state pluripotency. Development (2009) 5.49
A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells. Nature (2009) 5.46
JAK2 phosphorylates histone H3Y41 and excludes HP1alpha from chromatin. Nature (2009) 4.60
STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells. EMBO J (1999) 4.55
Suppression of SHP-2 and ERK signalling promotes self-renewal of mouse embryonic stem cells. Dev Biol (1999) 4.00
Metastable pluripotent states in NOD-mouse-derived ESCs. Cell Stem Cell (2009) 3.92
Epigenetic reversion of post-implantation epiblast to pluripotent embryonic stem cells. Nature (2009) 3.43
The origin and efficient derivation of embryonic stem cells in the mouse. Proc Natl Acad Sci U S A (1997) 3.39
Oct4 and LIF/Stat3 additively induce Krüppel factors to sustain embryonic stem cell self-renewal. Cell Stem Cell (2009) 3.27
Ability of the hydrophobic FGF and basic TAT peptides to promote cellular uptake of recombinant Cre recombinase: a tool for efficient genetic engineering of mammalian genomes. Proc Natl Acad Sci U S A (2002) 3.01
Conserved and divergent roles of FGF signaling in mouse epiblast stem cells and human embryonic stem cells. Cell Stem Cell (2010) 2.73
LIF/STAT3 signaling fails to maintain self-renewal of human embryonic stem cells. Stem Cells (2004) 2.37
SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130. J Biol Chem (2000) 2.14
Novel STAT3 target genes exert distinct roles in the inhibition of mesoderm and endoderm differentiation in cooperation with Nanog. Stem Cells (2009) 1.90
Self-renewing epiblast stem cells exhibit continual delineation of germ cells with epigenetic reprogramming in vitro. Development (2009) 1.66
Physiological rationale for responsiveness of mouse embryonic stem cells to gp130 cytokines. Development (2001) 1.56
Parameters influencing derivation of embryonic stem cells from murine embryos. Genesis (2008) 1.43
Signaling mechanisms regulating self-renewal and differentiation of pluripotent embryonic stem cells. Cells Tissues Organs (1999) 1.27
Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell (2003) 20.16
The ground state of embryonic stem cell self-renewal. Nature (2008) 19.44
BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell (2003) 13.47
Nanog safeguards pluripotency and mediates germline development. Nature (2007) 13.01
A protein interaction network for pluripotency of embryonic stem cells. Nature (2006) 9.63
Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture. Nat Biotechnol (2003) 9.41
Niche-independent symmetrical self-renewal of a mammalian tissue stem cell. PLoS Biol (2005) 9.12
Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol (2008) 8.55
Nanog is the gateway to the pluripotent ground state. Cell (2009) 7.27
Naive and primed pluripotent states. Cell Stem Cell (2009) 7.15
Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell (2009) 6.77
Capture of authentic embryonic stem cells from rat blastocysts. Cell (2008) 6.60
The transcriptional and epigenomic foundations of ground state pluripotency. Cell (2012) 5.87
FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage commitment. Development (2007) 5.62
Klf4 reverts developmentally programmed restriction of ground state pluripotency. Development (2009) 5.49
Capturing pluripotency. Cell (2008) 5.08
Signalling, cell cycle and pluripotency in embryonic stem cells. Trends Cell Biol (2002) 5.00
Self-renewal of teratocarcinoma and embryonic stem cells. Oncogene (2004) 4.40
Nanog promotes transfer of pluripotency after cell fusion. Nature (2006) 4.38
Suppression of Erk signalling promotes ground state pluripotency in the mouse embryo. Development (2009) 4.25
Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system. Cell Res (2013) 3.50
Oct4 and LIF/Stat3 additively induce Krüppel factors to sustain embryonic stem cell self-renewal. Cell Stem Cell (2009) 3.27
Inhibition of glycogen synthase kinase-3 alleviates Tcf3 repression of the pluripotency network and increases embryonic stem cell resistance to differentiation. Nat Cell Biol (2011) 3.25
Exit from pluripotency is gated by intracellular redistribution of the bHLH transcription factor Tfe3. Cell (2013) 3.15
Reprogramming efficiency following somatic cell nuclear transfer is influenced by the differentiation and methylation state of the donor nucleus. Stem Cells (2006) 3.07
Esrrb is a pivotal target of the Gsk3/Tcf3 axis regulating embryonic stem cell self-renewal. Cell Stem Cell (2012) 3.03
Screening for mammalian neural genes via fluorescence-activated cell sorter purification of neural precursors from Sox1-gfp knock-in mice. Proc Natl Acad Sci U S A (2003) 2.86
Functional gene screening in embryonic stem cells implicates Wnt antagonism in neural differentiation. Nat Biotechnol (2002) 2.64
NANOG-dependent function of TET1 and TET2 in establishment of pluripotency. Nature (2013) 2.63
Prmt5 is essential for early mouse development and acts in the cytoplasm to maintain ES cell pluripotency. Genes Dev (2010) 2.59
Naive pluripotency is associated with global DNA hypomethylation. Nat Struct Mol Biol (2013) 2.49
Validated germline-competent embryonic stem cell lines from nonobese diabetic mice. Nat Med (2009) 2.26
Genesis of embryonic stem cells. Philos Trans R Soc Lond B Biol Sci (2003) 1.97
Rapid and efficient reprogramming of somatic cells to induced pluripotent stem cells by retinoic acid receptor gamma and liver receptor homolog 1. Proc Natl Acad Sci U S A (2011) 1.97
Pluripotency in the embryo and in culture. Cold Spring Harb Perspect Biol (2012) 1.93
Adherent neural stem (NS) cells from fetal and adult forebrain. Cereb Cortex (2006) 1.88
Widespread resetting of DNA methylation in glioblastoma-initiating cells suppresses malignant cellular behavior in a lineage-dependent manner. Genes Dev (2013) 1.88
Nanog overcomes reprogramming barriers and induces pluripotency in minimal conditions. Curr Biol (2010) 1.86
Long-term tripotent differentiation capacity of human neural stem (NS) cells in adherent culture. Mol Cell Neurosci (2008) 1.62
The origin and identity of embryonic stem cells. Development (2011) 1.60
Normal timing of oligodendrocyte development from genetically engineered, lineage-selectable mouse ES cells. J Cell Sci (2002) 1.58
Embryonic germ cells from mice and rats exhibit properties consistent with a generic pluripotent ground state. Development (2010) 1.58
A genome-wide screen in EpiSCs identifies Nr5a nuclear receptors as potent inducers of ground state pluripotency. Development (2010) 1.51
CD133 (Prominin) negative human neural stem cells are clonogenic and tripotent. PLoS One (2009) 1.50
Identification of the missing pluripotency mediator downstream of leukaemia inhibitory factor. EMBO J (2013) 1.46
Human hypoblast formation is not dependent on FGF signalling. Dev Biol (2011) 1.46
Capture of neuroepithelial-like stem cells from pluripotent stem cells provides a versatile system for in vitro production of human neurons. PLoS One (2012) 1.46
A defined Oct4 level governs cell state transitions of pluripotency entry and differentiation into all embryonic lineages. Nat Cell Biol (2013) 1.45
Parameters influencing derivation of embryonic stem cells from murine embryos. Genesis (2008) 1.43
The nature of embryonic stem cells. Annu Rev Cell Dev Biol (2014) 1.40
'No' to ban on stem-cell patents. Nature (2011) 1.39
JAK/STAT3 signalling is sufficient and dominant over antagonistic cues for the establishment of naive pluripotency. Nat Commun (2012) 1.37
The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity. Neurobiol Dis (2012) 1.35
Treatment of a mouse model of spinal cord injury by transplantation of human induced pluripotent stem cell-derived long-term self-renewing neuroepithelial-like stem cells. Stem Cells (2012) 1.33
Robust self-renewal of rat embryonic stem cells requires fine-tuning of glycogen synthase kinase-3 inhibition. Stem Cell Reports (2013) 1.31
A PiggyBac-based recessive screening method to identify pluripotency regulators. PLoS One (2011) 1.30
Regulation of stem cell therapies under attack in Europe: for whom the bell tolls. EMBO J (2013) 1.28
Essential alterations of heparan sulfate during the differentiation of embryonic stem cells to Sox1-enhanced green fluorescent protein-expressing neural progenitor cells. Stem Cells (2007) 1.23
The liberation of embryonic stem cells. PLoS Genet (2011) 1.20
Fibroblast growth factor induces a neural stem cell phenotype in foetal forebrain progenitors and during embryonic stem cell differentiation. Mol Cell Neurosci (2008) 1.20
Germline potential of parthenogenetic haploid mouse embryonic stem cells. Development (2012) 1.19
Tripotential differentiation of adherently expandable neural stem (NS) cells. PLoS One (2007) 1.13
Rebuilding pluripotency from primordial germ cells. Stem Cell Reports (2013) 1.09
Interplay between FGF2 and BMP controls the self-renewal, dormancy and differentiation of rat neural stem cells. J Cell Sci (2011) 1.07
Isolation and propagation of enteric neural crest progenitor cells from mouse embryonic stem cells and embryos. Development (2010) 1.07
A genome-wide RNAi screen reveals MAP kinase phosphatases as key ERK pathway regulators during embryonic stem cell differentiation. PLoS Genet (2012) 1.05
Stem cells: Fusion brings down barriers. Nature (2003) 1.05
Site-directed, virus-free, and inducible RNAi in embryonic stem cells. Proc Natl Acad Sci U S A (2007) 0.99
Reprogramming capacity of Nanog is functionally conserved in vertebrates and resides in a unique homeodomain. Development (2011) 0.96
Sox2 and Pax6 maintain the proliferative and developmental potential of gliogenic neural stem cells In vitro. Glia (2011) 0.95
The mammalian germline as a pluripotency cycle. Development (2013) 0.93
Isolation of homozygous mutant mouse embryonic stem cells using a dual selection system. Nucleic Acids Res (2011) 0.88
A high-content small molecule screen identifies sensitivity of glioblastoma stem cells to inhibition of polo-like kinase 1. PLoS One (2013) 0.86
Therapeutic bilateral lung lavage in a child with pulmonary alveolar proteinosis. Pediatr Crit Care Med (2010) 0.86
Matrix remodeling maintains embryonic stem cell self-renewal by activating Stat3. Stem Cells (2013) 0.85
Unequal segregation of parental chromosomes in embryonic stem cell hybrids. Mol Reprod Dev (2005) 0.85
Stem cells expanded from the human embryonic hindbrain stably retain regional specification and high neurogenic potency. J Neurosci (2013) 0.83
Automated large-scale culture and medium-throughput chemical screen for modulators of proliferation and viability of human induced pluripotent stem cell-derived neuroepithelial-like stem cells. J Biomol Screen (2012) 0.83
Differentiation of human induced pluripotent stem cells into brown and white adipocytes: role of Pax3. Stem Cells (2014) 0.82
Neural stem cells engrafted in the adult brain fuse with endogenous neurons. Stem Cells Dev (2012) 0.82
Induction of superficial cortical layer neurons from mouse embryonic stem cells by valproic acid. Neurosci Res (2011) 0.81
Exploitation of adherent neural stem cells in basic and applied neurobiology. Regen Med (2006) 0.81
IL-15Rα deficiency leads to mitochondrial and myofiber differences in fast mouse muscles. Cytokine (2012) 0.80
Human embryonic stem cells. Science (2005) 0.77
Looking inwards: opening a window onto human development. Development (2015) 0.76
A novel combined bisulfite UDG assay for selective 5-methylcytosine detection. Talanta (2013) 0.76
Microparticles as novel biomarkers and therapeutic targets in coronary heart disease. Chin Med J (Engl) (2015) 0.75
Human embryonic stem cells: prospects for human health - a 1-day international symposium held at the University of Sheffield. J Anat (2002) 0.75
Corrigendum: Failure to replicate the STAP cell phenomenon. Nature (2015) 0.75
Stem cells and regeneration: a special issue. Development (2013) 0.75
Retraction. Nature (2014) 0.75
Moral Distress and Associated Factors Among Baccalaureate Nursing Students: A Multisite Descriptive Study. Nurs Educ Perspect (2017) 0.75
[The clinical evaluation of treatment of 127 cases molar acute endodontitis]. Shanghai Kou Qiang Yi Xue (2003) 0.75
An interview with Austin Smith. Development (2015) 0.75